Never miss a Delaware County story!
Seven Philadelphia-area companies made the 2024 Deloitte Technology Fast 500 list, including two from Delaware County, writes Ryan Mulligan for Philadelphia Business Journal.
Deloitte…
Marinus Pharmaceuticals of Radnor saw its stock price plunge by more than 80 percent Monday because of a setback in an experimental seizure drug, writes…
The president of Cheyney University and the CEO of Radnor-based Marinus Pharmaceuticals made a Philadelphia Business Journal list of the 26 most admired CEOs…
The CEO of a Radnor-based pharmaceutical company, Dr. Scott Braunstein, M.D., has made a top 25 list of Biotech CEOs for 2022, compiled…
A Radnor pharmaceutical company specializing in new therapies for rare seizure disorders is raising $70 million through a public stock offering this week, writes John…
Radnor’s Marinus Pharmaceuticals is looking to raise $35 million from its public offering of 9.3 million shares of its common stock priced at…
Marinus Pharmaceuticals in Radnor is getting a jumpstart over the competition in the race to develop a treatment for the rare, autism-like Fragile X…
Before we send you to this site, please subscribe to our daily newsletter.
